Quick Answer
aTYR PHARMA INC reported Net Income of -$74.12 million for fiscal year 2025.
aTYR PHARMA INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$74.12M | -15.8% |
| 2024 | -$64.02M | -27.1% |
| 2023 | -$50.39M | -11.1% |
| 2022 | -$45.34M | -34.3% |
| 2021 | -$33.77M | -108.1% |
| 2020 | -$16.22M | +0.0% |
| 2019 | -$16.22M | +53.0% |
| 2018 | -$34.52M | +28.4% |
| 2017 | -$48.21M | +16.7% |
| 2016 | -$57.85M | -20.6% |
| 2015 | -$47.97M | -97.0% |
| 2014 | -$24.35M | -21.7% |
| 2013 | -$20.01M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.74M | -49.2% | -31.8% |
| June 30, 2025 | -$19.53M | -19.8% | -31.3% |
| March 31, 2025 | -$14.88M | +3.9% | +13.8% |
| September 30, 2024 | -$17.26M | -52.2% | -5.8% |
| June 30, 2024 | -$16.31M | -32.2% | -5.3% |
| March 31, 2024 | -$15.49M | -29.6% | -36.6% |
| September 30, 2023 | -$11.34M | +14.4% | +8.1% |
| June 30, 2023 | -$12.34M | +0.7% | -3.2% |
- aTYR PHARMA INC showed a decrease of -15.8% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, aTYR PHARMA INC’s net income has declined by 270.3% (from -$20.01 million to -$74.12 million).
- The most recent figure is from aTYR PHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: